NBW: System, Test, Blood Glucose, Over The Counter
What it covers
A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.
The identification in 21 CFR 862.1345, glucose test system. FDA gives NBW no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260687 | VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual Monitoring System. | Vivachek Biotech (Hangzhou) Co., Ltd. | Oct 9, 2026 | Traditional |
| K260689 | CVS Advanced PLUS Blood Glucose Monitoring System | I-Sens, Inc. | Oct 2, 2026 | Special |
| K260545 | CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System; CONTOUR® NEXT ONE Blood Glucose Monitoring System | Ascensia Diabetes Care | Aug 27, 2026 | Traditional |
| K262116 | TRUE METRIX Self Monitoring Blood Glucose System | Trividia Health, Inc. | Jul 23, 2026 | Special |
| K250085 | On Call® Sure GK Blood Glucose & Ketone Monitoring System; On Call® Sure Sync GK Blood Glucose & Ketone Monitoring System | ACON Laboratories, Inc. | Oct 10, 2025 | Traditional |
| K243060 | TeleRPM Gen2 Blood Glucose Monitoring System | Guangdong Transtek Medical Electronics Co., Ltd. | Jan 30, 2025 | Traditional |
| K240637 | RIGHTEST Blood Glucose Monitoring System Max Tel | Bionime Corporation | Nov 4, 2024 | Traditional |
| K240640 | Sejoy Blood Glucose Monitoring System; Sejoy Advance Link Blood Glucose Monitoring System | Sejoy Biomedical Co., Ltd. | Oct 8, 2024 | Traditional |
| K241787 | CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System | Ascensia Diabetes Care U.S., Inc. | Aug 27, 2024 | Traditional |
| K222126 | VivaChek Fad Blood Glucose Monitoring System, VivaChek Fad Smart Blood Glucose Monitoring System, VivaChek Fad Sync Blood Glucose Monitoring System | Vivachek Biotech (Hangzhou) Co., Ltd. | Aug 16, 2024 | Traditional |
Clearances by year
281 NBW 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 4 | 202 |
| 2025 | 2 | 198 |
| 2024 | 7 | 243 |
| 2023 | 5 | 193 |
| 2022 | 12 | 410 |
| 2021 | 7 | 465 |
| 2020 | 7 | 121 |
| 2019 | 10 | 127 |
| 2018 | 19 | 168 |
| 2017 | 25 | 244 |
| 2016 | 20 | 233 |
| 2015 | 32 | 237 |
| 2014 | 24 | 202 |
| 2013 | 47 | 167 |
| 2012 | 30 | 230 |
| 2011 | 30 | 328 |
Who submits
91 applicants cleared a NBW device since 2011. 44% of the clearances went to applicants in United States, then Taiwan (30%), South Korea (12%) and China (11%). By type: Traditional 63% and Special 37%.
| Applicant | Clearances since 2011 |
|---|---|
| Taidoc Technology Corporation | 20 |
| I-Sens, Inc. | 19 |
| Apex BioTechnology Corp. | 16 |
| ACON Laboratories, Inc. | 11 |
| Bionime Corporation | 11 |
| Infopia Co, Ltd. | 10 |
| Andon Health Co, Ltd. | 7 |
| Andon Medical Co., Ltd. | 7 |
How FDA classifies it
Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
From 21 CFR 862.1345. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 862.1345 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NBW clearances declared.
Ask about NBW
Questions about NBW
What is FDA product code NBW?
Product code NBW, “System, Test, Blood Glucose, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.1345 (glucose test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 512 clearances under NBW, 281 of them since 2011.
How many 510(k) clearances are there under NBW?
FDA’s 510(k) database listed 512 clearances under NBW as of Oct 29, 2026, 281 of them decided since 2011; the most recent decision was Oct 9, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a NBW 510(k)?
For the 7 NBW clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 213 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most NBW clearances?
Since 2011: Taidoc Technology Corporation (20), I-Sens, Inc. (19), Apex BioTechnology Corp. (16), ACON Laboratories, Inc. (11) and Bionime Corporation (11). 91 applicants have cleared a NBW device in that time.